Essentials of Pain Medicine E-book: Edition 3
About this ebook
All chapters are brief and easy to read quickly.
Offers specific strategies for the evaluation and management of a full range of pain syndromes, including cancer pain.
Features over 230 diagrams, illustrations, summary charts and tables that clarify the information and make it easy to apply.
Discusses the latest drugs and therapeutic approaches, such as acupuncture.
Presents the management of pain for every setting where it is practiced, including the emergency room, the critical care unit, and the pain clinic.Includes new topics such as: imaging in pain medicine, radiation safety, issues associated with the use of narcotics, intraarticular and intraperitoneal use of opioids, pain management in the emergency room and in the intensive care unit, pain management issues during pregnancy, geriatric pain, and hospice care and end-of-life issues. New chapters on interventional procedures include discography, intradiscal electrothermal coagulation (IDET), vertebroplasty, and piriformis injections. Truncal blocks and neuraxial blocks and anticoagulants are added to the section on nerve blocks.
Ratings and reviews
About the author
Scott Fishman has more than three decades’ experience as a strategic advisor to the medical technology and pharmaceutical industries. He founded and was CEO of Research by Design (RBD), a healthcare consultancy he grew to one of the foremost names in the medical information industry. He has counseled virtually every major pharmaceutical company, as well as a wide spectrum of biotechnology and medical device companies. He is currently President and CEO of Ethos LifeScience Advisors and Envisage, consultancies that provide market analysis and commercial guidance for healthcare entrepreneurs starting new ventures and for new product developers working within pharmaceutical, biotech, and medical device companies. Fishman is an enthusiastic angel investor who focuses on medical technologies. He previously chaired the Life Sciences screening committee for Robin Hood Ventures and sits on the Life Science Investment Review committee for Ben Franklin Technology Partners. He co-created and serves as program executive for the Commercialization Acceleration Program (CAP) at the Wharton School of the University of Pennsylvania, a consultancy focused on the development and funding of technology-based start-up companies. Fishman holds undergraduate and graduate degrees from the University of Pennsylvania and The University of Texas, teaches in the MBA program at Philadelphia University, and is an in-demand speaker at biotechnology development events around the United States, including recent engagements at Yale’s Healthcare Colloquium, Harvard’s i-lab, and the National Science Foundation.